Preferred Name |
Bezafibrate |
|
Synonyms |
2-(p-(2-(p-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropionic Acid Bezafibrate Propanoic Acid, 2-(4-(2-((4-Chlorobenzoyl)Amino)Ethyl)Phenoxy)-2-Methyl- BEZAFIBRATE BM 15.075 Bezalip |
|
Definitions |
An agonist of peroxisome proliferator-activated receptor alpha (PPARalpha) with antilipidemic activity. Bezafibrate decreases triglyceride levels, increases high density lipoprotein (HDL) cholesterol levels, and decreases total and low density lipoprotein (LDL) cholesterol levels. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C87449 |
|
CAS_Registry |
41859-67-0 |
|
CHEBI_ID |
CHEBI:47612 |
|
Chemical_Formula |
C19H20ClNO4 |
|
code |
C87449 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
An agonist of peroxisome proliferator-activated receptor alpha (PPARalpha) with antilipidemic activity. Bezafibrate decreases triglyceride levels, increases high density lipoprotein (HDL) cholesterol levels, and decreases total and low density lipoprotein (LDL) cholesterol levels. |
|
FDA_UNII_Code |
Y9449Q51XH |
|
FULL_SYN |
2-(p-(2-(p-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropionic Acid Bezafibrate Propanoic Acid, 2-(4-(2-((4-Chlorobenzoyl)Amino)Ethyl)Phenoxy)-2-Methyl- BEZAFIBRATE BM 15.075 Bezalip |
|
label |
Bezafibrate |
|
Preferred_Name |
Bezafibrate |
|
prefixIRI |
Thesaurus:C87449 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0005330 |
|
subClassOf |